ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,070 filers reported holding ASTRAZENECA PLC in Q2 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,553,937,240 | -0.4% | 22,946,504 | +5.2% | 1.32% | +3.0% |
| Q2 2023 | $1,560,741,964 | +38.9% | 21,807,209 | +34.7% | 1.28% | +24.2% |
| Q1 2023 | $1,123,758,661 | +213.0% | 16,190,155 | +205.8% | 1.03% | +183.2% |
| Q4 2022 | $358,991,034 | +47.4% | 5,294,853 | +19.2% | 0.36% | +50.4% |
| Q3 2022 | $243,581,000 | -10.4% | 4,441,663 | +7.9% | 0.24% | -10.7% |
| Q2 2022 | $271,900,000 | +12.1% | 4,115,326 | +12.5% | 0.27% | +51.4% |
| Q1 2022 | $242,638,000 | +47.7% | 3,657,490 | +29.7% | 0.18% | +72.1% |
| Q4 2021 | $164,260,000 | -10.3% | 2,819,915 | -7.5% | 0.10% | -11.9% |
| Q3 2021 | $183,112,000 | +0.3% | 3,048,818 | -0.0% | 0.12% | -2.5% |
| Q2 2021 | $182,625,000 | +25.3% | 3,048,839 | +4.0% | 0.12% | +13.1% |
| Q1 2021 | $145,788,000 | -70.6% | 2,932,179 | -70.5% | 0.11% | -69.8% |
| Q4 2020 | $496,164,000 | -70.8% | 9,925,270 | -68.0% | 0.35% | -74.1% |
| Q3 2020 | $1,700,743,000 | -17.8% | 31,035,458 | -20.7% | 1.37% | -26.9% |
| Q2 2020 | $2,069,783,000 | +19.4% | 39,133,736 | +0.9% | 1.87% | -11.1% |
| Q1 2020 | $1,732,903,000 | -5.2% | 38,802,123 | +5.9% | 2.10% | +14.2% |
| Q4 2019 | $1,827,566,000 | +13.9% | 36,653,958 | +1.9% | 1.84% | +8.9% |
| Q3 2019 | $1,603,837,000 | +14.6% | 35,984,685 | +6.2% | 1.69% | +22.0% |
| Q2 2019 | $1,398,900,000 | -20.4% | 33,888,085 | -22.0% | 1.39% | -20.4% |
| Q1 2019 | $1,757,174,000 | +1.0% | 43,462,141 | -5.1% | 1.74% | -10.4% |
| Q4 2018 | $1,739,362,000 | +10.6% | 45,796,787 | +15.2% | 1.95% | +34.4% |
| Q3 2018 | $1,572,682,000 | +132.4% | 39,744,304 | +106.2% | 1.45% | +119.4% |
| Q2 2018 | $676,716,000 | +540.7% | 19,274,167 | +522.1% | 0.66% | +489.3% |
| Q2 2017 | $105,621,000 | +27.0% | 3,098,301 | +16.0% | 0.11% | +25.8% |
| Q1 2017 | $83,197,000 | +33.0% | 2,671,709 | +16.7% | 0.09% | +27.1% |
| Q4 2016 | $62,535,000 | +123.8% | 2,288,989 | +169.2% | 0.07% | +133.3% |
| Q3 2016 | $27,944,000 | +8.2% | 850,391 | -0.6% | 0.03% | +7.1% |
| Q2 2016 | $25,818,000 | -69.8% | 855,191 | -71.8% | 0.03% | -68.9% |
| Q1 2016 | $85,464,000 | -16.1% | 3,034,935 | +1.2% | 0.09% | -10.0% |
| Q4 2015 | $101,820,000 | -18.1% | 2,999,120 | -23.2% | 0.10% | -21.3% |
| Q3 2015 | $124,300,000 | +45.3% | 3,906,335 | +191.0% | 0.13% | +62.8% |
| Q2 2015 | $85,531,000 | -6.1% | 1,342,507 | +0.9% | 0.08% | -6.0% |
| Q1 2015 | $91,075,000 | +35.9% | 1,330,929 | +39.7% | 0.08% | +31.7% |
| Q4 2014 | $67,039,000 | -8.7% | 952,529 | -15.9% | 0.06% | -10.0% |
| Q1 2014 | $73,465,000 | – | 1,132,321 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |